Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration

Experimental Cell Research

Volumn 316, Issue 5, 2010, Pages 875-886

  Arulanandam, Rozanne ^a   Geletu, Mulu ^a   Feracci, Hélène ^b   Raptis, Leda ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cell migration; Erk1 2; gp130; IL6; Rac Cdc42; Stat3

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; MESSENGER RNA; RAC1 PROTEIN; STAT3 PROTEIN; TYROSINE;

ANIMAL CELL; ARTICLE; CELL DENSITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UPREGULATION;

EID: 76749127892     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.10.017     Document Type: Article

References (38)

1. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology. Nature 420 (2002) 629-635
2. Perona R., Montaner S., Saniger L., Sanchez-Perez I., Bravo R., and Lacal J.C. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 11 (1997) 463-475
3. Joyce D., Bouzahzah B., Fu M., Albanese C., D'Amico M., Steer J., Klein J.U., Lee R.J., Segall J.E., Westwick J.K., Der C.J., and Pestell R.G. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J. Biol. Chem. 274 (1999) 25245-25249
4. Frank D.A. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett. 251 (2007) 199-210
5. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., and Darnell Jr. J.E. Stat3 as an oncogene. Cell 98 (1999) 295-303
6. Hung W., and Elliott B. Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells. J. Biol. Chem. 276 (2001) 12395-12403
7. Niu G., Wright K.L., Ma Y., Wright G.M., Huang M., Irby R., Briggs J., Karras J., Cress W.D., Pardoll D., Jove R., Chen J., and Yu H. Role of Stat3 in regulating p53 expression and function. Mol. Cell. Biol. 25 (2005) 7432-7440
8. Yu H., and Jove R. The STATs of cancer-new molecular targets come of age. Nat. Rev., Cancer 4 (2004) 97-105
9. Simon A.R., Vikis H.G., Stewart S., Fanburg B.L., Cochran B.H., and Guan K.L. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 290 (2000) 144-147
10. Faruqi T.R., Gomez D., Bustelo X.R., Bar-Sagi D., and Reich N.C. Rac1 mediates STAT3 activation by autocrine IL-6. Proc. Nat. Acad. Sci. U. S. A. 98 (2001) 9014-9019
11. Debidda M., Wang L., Zang H., Poli V., and Zheng Y. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J. Biol. Chem. 280 (2005) 17275-17285
12. Vultur A., Cao J., Arulanandam R., Turkson J., Jove R., Greer P., Craig A., Elliott B.E., and Raptis L. Cell to cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene 23 (2004) 2600-2616
13. Onishi A., Chen Q., Humtsoe J.O., and Kramer R.H. STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells. Exp. Cell Res. 314 (2008) 377-386
14. Steinman R.A., Wentzel A., Lu Y., Stehle C., and Grandis J.R. Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2. Oncogene 22 (2003) 3608-3615
15. Su H.W., Yeh H.H., Wang S.W., Shen M.R., Chen T.L., Kiela P.R., Ghishan F.K., and Tang M.J. Cell confluence-induced activation of signal transducer and activator of transcription-3 (Stat3) triggers epithelial dome formation via augmentation of sodium hydrogen exchanger-3 (NHE3) expression. J. Biol. Chem. 282 (2007) 9883-9894
16. Kreis S., Munz G.A., Haan S., Heinrich P.C., and Behrmann I. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases. Mol. Cancer Res. 5 (2007) 1331-1341
17. Ball R.K., Friis R.R., Schoenenberger C.A., Doppler W., and Groner B. Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 7 (1988) 2089-2095
18. Littlefield S.L., Baird M.C., Anagnostopoulou A., and Raptis L. Synthesis, characterization and Stat3 inhibitory properties of the prototypical platinum(IV) anticancer drug, [PtCl3(NO2)(NH3)2] (CPA-7). Inorg. Chem. 47 (2008) 2798-2804
19. Sander E.E., van Delft S., ten Klooster J.P., Reid T., van der Kammen R.A., Michiels F., and Collard J.G. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J. Cell Biol. 143 (1998) 1385-1398
20. Arulanandam R., Vultur A., Cao J., Carefoot E., Truesdell P., Elliott B., Larue L., Feracci H., and Raptis L. Cadherin-cadherin engagement promotes survival via Rac/Cdc42 and Stat3. Mol. Cancer Res. 17 (2009) 1310-1327
21. Tsubuki S., Saito Y., Tomioka M., Ito H., and Kawashima S. Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J. Biochem. 119 (1996) 572-576
22. Zhu Q., Wani G., Yao J., Patnaik S., Wang Q.E., El Mahdy M.A., Praetorius-Ibba M., and Wani A.A. The ubiquitin-proteasome system regulates p53-mediated transcription at p21waf1 promoter. Oncogene 26 (2007) 4199-4208
23. Treier M., Staszewski L.M., and Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78 (1994) 787-798
24. Lynch E.A., Stall J., Schmidt G., Chavrier P., and D'Souza-Schorey C. Proteasome-mediated degradation of Rac1-GTP during epithelial cell scattering. Mol. Biol. Cell 17 (2006) 2236-2242
25. Pop M., Aktories K., and Schmidt G. Isotype-specific degradation of Rac activated by the cytotoxic necrotizing factor 1. J. Biol. Chem. 279 (2004) 35840-35848
26. Narimatsu M., Maeda H., Itoh S., Atsumi T., Ohtani T., Nishida K., Itoh M., Kamimura D., Park S.J., Mizuno K., Miyazaki J., Hibi M., Ishihara K., Nakajima K., and Hirano T. Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol. Cell. Biol. 21 (2001) 6615-6625
27. Sulciner D.J., Irani K., Yu Z.X., Ferrans V.J., Goldschmidt-Clermont P., and Finkel T. rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol. Cell. Biol. 16 (1996) 7115-7121
28. Gauzzi M.C., Velazquez L., McKendry R., Mogensen K.E., Fellous M., and Pellegrini S. Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J. Biol. Chem. 271 (1996) 20494-20500
29. Leonard W.J., and O'Shea J.J. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16 (1998) 293-322
30. Zhang Y., Turkson J., Carter-Su C., Smithgall T., Levitzki A., Kraker A., Krolewski J.J., Medveczky P., and Jove R. Activation of Stat3 in v-Src transformed fibroblasts requires cooperation of Jak1 kinase activity. J. Biol. Chem. 275 (2000) 24935-24944
31. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., Kaminski K., Schaefer A., Schieffer B., Hillmer A., Schmiedl A., Ding Z., Podewski E., Podewski E., Poli V., Schneider M.D., Schulz R., Park J.K., Wollert K.C., and Drexler H. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ. Res. 95 (2004) 187-195
32. Fischer P., and Hilfiker-Kleiner D. Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects. Br. J. Pharmacol. 153 Suppl. 1 (2008) S414-S427
33. Guo F., and Zheng Y. Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts. Mol. Cell Biol. 24 (2004) 1426-1438
34. Nobes C.D., and Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144 (1999) 1235-1244
35. Geletu M., Chaize C., Arulanandam R., Vultur A., Kowolik C., Anagnostopoulou A., Jove R., and Raptis L. Stat3 activity is required for gap junctional permeability in normal epithelial cells and fibroblasts. DNA Cell Biol. 28 (2009) 319-327
36. Vultur A., Arulanandam R., Turkson J., Niu G., Jove R., and Raptis L. Stat3 is required for full neoplastic transformation by the Simian Virus 40 Large Tumor antigen. Mol. Biol. Cell 16 (2005) 3832-3846
37. Raptis L., Arulanandam R., Vultur A., Geletu M., Chevalier S., and Feracci H. Beyond structure, to survival: Stat3 activation by cadherin engagement. Biochem. Cell Biol. 87 (2009) 835-843
38. Lazo J.S., Nemoto K., Pestell K.E., Cooley K., Southwick E.C., Mitchell D.A., Furey W., Gussio R., Zaharevitz D.W., Joo B., and Wipf P. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors. Mol. Pharmacol. 61 (2002) 720-728